Business Description
Delta-Fly Pharma Inc
ISIN : JP3549370009
Share Class Description:
TSE:4598: Ordinary SharesDescription
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.6 | |||||
| 3-Year EPS without NRI Growth Rate | 12.4 | |||||
| 3-Year FCF Growth Rate | 14.8 | |||||
| 3-Year Book Growth Rate | -35.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.62 | |||||
| 9-Day RSI | 33.27 | |||||
| 14-Day RSI | 37.9 | |||||
| 6-1 Month Momentum % | -36.15 | |||||
| 12-1 Month Momentum % | -29.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.12 | |||||
| Quick Ratio | 19.12 | |||||
| Cash Ratio | 18.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -145 | |||||
| ROA % | -128.45 | |||||
| ROIC % | -2009.88 | |||||
| ROC (Joel Greenblatt) % | -3215.18 | |||||
| ROCE % | -142.19 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.79 | |||||
| Price-to-Tangible-Book | 3.79 | |||||
| EV-to-EBIT | -4.52 | |||||
| EV-to-EBITDA | -4.52 | |||||
| EV-to-FCF | -4.3 | |||||
| Price-to-Net-Current-Asset-Value | 3.88 | |||||
| Price-to-Net-Cash | 3.91 | |||||
| Earnings Yield (Greenblatt) % | -22.12 | |||||
| FCF Yield % | -20.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Delta-Fly Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -187.697 | ||
| Beta | -1.95 | ||
| Volatility % | 71.68 | ||
| 14-Day RSI | 37.9 | ||
| 14-Day ATR (円) | 22.658104 | ||
| 20-Day SMA (円) | 813.55 | ||
| 12-1 Month Momentum % | -29.24 | ||
| 52-Week Range (円) | 762 - 1825 | ||
| Shares Outstanding (Mil) | 8.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Delta-Fly Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Delta-Fly Pharma Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Delta-Fly Pharma Inc Frequently Asked Questions
What is Delta-Fly Pharma Inc(TSE:4598)'s stock price today?
The current price of TSE:4598 is 円778.00. The 52 week high of TSE:4598 is 円1825.00 and 52 week low is 円762.00.
When is next earnings date of Delta-Fly Pharma Inc(TSE:4598)?
The next earnings date of Delta-Fly Pharma Inc(TSE:4598) is .
Does Delta-Fly Pharma Inc(TSE:4598) pay dividends? If so, how much?
Delta-Fly Pharma Inc(TSE:4598) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers